CTI BioPharma Corp.'s data from its PERSIST-2 Phase 3 clinical study was presented as a late-breaking oral session at the 58th American Society of Hematology Annual Meeting, which was held in San Diego Dec. 3-6. Read More »
The CVS Health Institute and the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response recently released research showing that automated notifications sent out by pharmacies are helping patients with chronic conditions remember to refill their medications before forecast natural disasters hit. Read More »
As National Influenza Vaccination Week runs through Saturday, CVS Pharmacy is reminding families across the U.S. that it is not too late to get their flu shots. Read More »
Rite Aid has announced that their customers will be able to save $5 on flu shots during National Influenza Vaccination Week in support of the cause. Read More »
Remedy Pharmaceuticals has named David Epstein a special adviser to the Board of Directors. Read More »
Amgen presented data from its Phase 3 TOWER study at the 58th Annual Meeting and Exposition of the American Society of Hematology this week in San Diego. Read More »
OptumRx and CVS Pharmacy say their collaboration that will provide improved health outcomes that are cost-efficient for consumers and clients while giving them more suitable choices. Read More »
Eisai Inc. has released the final results of its Phase 3 rufinamide study, an open-label, two-year investigation. Read More »
AbbVie's risankizumab has been granted Orphan Drug Designation by the U.S. Food and Drug Administration for the investigational treatment of pediatric patients who have Crohn’s disease. Read More »
Cigna will be implementing an integrated hi-tech/hi-touch approach when it comes to the support and service of its customers. Read More »
Upsher-Smith Laboratories Inc. will have three poster presentations at the American Epilepsy Society’s 70th annual meeting, running through Tuesday in Houston. Read More »
Otsuka Pharmaceuticals and Lundbeck's supplemental New Drug Application for the expanded labeling of ABILIFY MAINENA has been completed and will receive a substantive review by the U.S. Food and Drug Administration. Read More »
Biological Industries' Drug Master File for NutriStem hPSC XF Medium has been accepted by the U.S. Food and Drug Administration. Read More »
The U.S. Food and Drug Administration has approved Armodafinil Tablets developed by Lupin Pharmaceuticals. Read More »
Omnicell has finalized an agreement for the acquisition of Ateb Inc. and its affiliate, Ateb Canada Ltd. Read More »
To kick off the holiday season, Cigna has released “Holiday Survival Tips.” Read More »
The American Journal of Health-System Pharmacy has launched its redesigned website, AJHP.org. Read More »
The American Society of Health System Pharmacists is accepting applications for its 2017 ASHP Executive Residency in Association Leadership and Management. Read More »
Naloxone has been made available without the need for a prescription in all Walgreens pharmacy locations in the Louisiana. Read More »
Amgen will partner with Janssen Biotech to assess the drug combination made up of KYPROLIS, developed by Amgen, and DARZALEX, developed by Janssen, over the course of multiple clinical trials for the treatment of patients who have multiple myeloma. Read More »
Alerts Sign-up
